Global Health Matters

8 March 2019 - By Unjela Kaleem
This blog was first published on Pharma Boardroom on 8 March 2019. The jury is still out there regarding the impact of technological advancements on our overall life styles, but it’s hard to deny the positive impact technology has had on women’s social, political, economic and religious status in societies ...
Read More
7 March 2019 - By Thomas B. Cueni
This oped was first published on Pharma Focus Asia on 7 March 2019. Seventy years ago, average life expectancy globally was 47; today it is 72. Seventy years ago, 50 million people worldwide were infected with smallpox; today none. The disease is eradicated. Thanks to initiatives such as Gavi (the ...
Read More
5 March 2019 - By Laetitia Bigger
Laetitia Bigger, Director, Vaccines Policy at IFPMA, spoke with Jenny Sia, Director of Corporate Responsibility at the Pfizer Foundation, about innovations in mHealth technology that are helping to increase access to vaccines. Jenny leads global health grant making and impact investing for the Pfizer Foundation, a charitable organization aiming to ...
Read More
7 February 2019 - By Fumie Griego
Since the start of the 21st century, Gavi, the Vaccine Alliance, has transformed lives, preventing more than 10 million potential deaths. In 2002, when AIDS, TB and malaria appeared unstoppable, the Global Fund to fight these three fatal diseases was created and since then has saved millions of lives – ...
Read More
30 January 2019 - By Thomas Cueni & Viriya Chongphaisal
This oped was first published on The Nation  on 30 January 2019. It's clear we live in a global village when England striker Jamie Vardy of Thai-owned Leicester City[1] praises Thai rocker Toon Bodyslam's 2,215 km charity run over 55 days in 2017 that raised Bt1.37 billion/$35 million for 11 public ...
Read More
24 January 2019 - By Greg Perry
“This blog was first published in Pharma Exec on 23 January 2019"   As a Brit living and working abroad, I am transfixed by what I’m witnessing together with many others, as the fallout from the June 2016 referendum continues to wrack the UK political landscape. As scenarios, timelines, policy ...
Read More
17 January 2019 - By Thomas B. Cueni
This oped was published first on IP Watch on 16 January 2019 The views expressed in this article are solely those of the authors and are not associated with Intellectual Property Watch. IP-Watch expressly disclaims and refuses any responsibility or liability for the content, style or form of any posts ...
Read More
11 January 2019 - By Greg Perry
For millions of people worldwide out-of-pocket health expenses translate to out-of-reach opportunities for the future. Children miss out on essential immunizations, women die giving birth in unsafe environments, and people are at risk of going blind or having a stroke before they realize they are not properly controlling their diabetes. ...
Read More
18 December 2018 - By Thomas B. Cueni
This oped was first published on IAPO Newsletter on 17 December 2018. An efficient healthcare system depends on mutual trust between patients, healthcare professionals, regulators and pharmaceutical companies – but how should that translate concretely into the day to day reality of whether a healthcare professional should be given a ...
Read More
13 December 2018 - By Thomas B. Cueni
This oped was first published first on PharmaBoardroom on 12 December 2018.   At least half of the world’s population cannot obtain essential health services, according to a 2017 report from the World Bank and World Health Organization[1]. And each year, large numbers of households are being pushed into poverty ...
Read More
6 December 2018 - By Thomas B. Cueni
This oped was first published in The Pharma Letter on 6 December 2018. Business performance is mostly about the tangible: robust pipeline, successful launches, development of sales, financial results, profit margins, and the like. One less tangible but absolutely crucial measure of success relates to “how” we go about our ...
Read More
13 November 2018 - By Thomas B. Cueni
This oped was first published in the Antimicrobial Resistance campaign in the Guardian on 12 November 2018   Antimicrobial resistance (AMR) is on course to overtake cancer and account for 10m deaths a year by 2050. Already, 700,000 people die from drug-resistant infections (“superbugs”) each year. AMR could cost the ...
Read More
26 October 2018 - By Thomas B. Cueni
This oped was first published on AGEGI on 25 October 2018. Résumé : Avec Ebola chaque pays est vulnérable face aux épidémies et la solution passe par une couverture universelle de santé et un travail collectif Même si l’Organisation Mondiale de la Santé (OMS) a récemment décidé qu’il n’y a pas ...
Read More
4 October 2018 - By Thomas B. Cueni
This oped was first published in the World Medical Journal (Vol. 64, September2018). An efficient healthcare system depends on mutual trust between all parties – but how should that translate concretely into the day to day reality of whether a healthcare professional should be given a subscription to a journal ...
Read More
28 September 2018 - By Thomas B. Cueni
This oped was first published on Health Policy Watch on 28 September 2018. It’s often hard to see progress when the realities surrounding you are bleak: non-communicable diseases (NCDs) are the world’s biggest killer, responsible for around 70 percent of global deaths. Each year some 40 million people die of ...
Read More